{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:07:52Z","timestamp":1761764872693},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T00:00:00Z","timestamp":1130284800000},"content-version":"vor","delay-in-days":4165,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet. Cardiovasc. Diagn."],"published-print":{"date-parts":[[1994,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Subacute thrombosis of coronary stents may occur up to the end of the first month after their implantation and remains the major problem associated with the technique. A cohort of 238 patients with placement of one or more stents in 244 arteries was monitored for this period. All patients were given 500 mg\/day of ticlopidine (started 3 days before) and a push dose of 10,000 IU of heparin during the procedure, then 1,000\u20131,500 IU\/hr for 20 hr. Following removal of the arterial introducer, they were kept on subcutaneous heparin for 1 week and ticlopidine (500 mg\/day) for 3\u20136 months. Nine patients (3.8%) showed evidence of thrombosis at 7 days. The overall thrombosis rate at 30 days was 4.2% (3.5% for elective stents, as compared with 7.9% associated with occlusive dissections). Emergency treatment by further angioplasty (8 cases) and intracoronary thrombolysis (5 cases) was undertaken. Complications were as follows: 5 deaths (2%), 3 Ml (1.2%), 2 non\u2010Q Ml (1.7%). Three predictive factors for subacute thrombosis were identified: age &lt;70 (<jats:italic>p<\/jats:italic> = 0.00006), unstable angina (<jats:italic>p<\/jats:italic> = 0.006) and arterial diameter less than 3 mm (<jats:italic>p<\/jats:italic> = 0.043). The peripheral vascular complication rate was 4.6%. This study suggests that preventive treatment with ticlopidine appears to reduce the incidence of sub\u2010acute thrombosis of stents in patients &gt;70 years of age. Furthermore, the combination of ticlopidine and heparin facilitates laboratory monitoring after stenting. Stenting is thought to represent definitive treatment in situations where placement for occlusive dissection is the indication. \u00a9 1994 Wiley\u2010Liss,Inc..<\/jats:p>","DOI":"10.1002\/ccd.1810320208","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T04:49:44Z","timestamp":1172810984000},"page":"133-138","source":"Crossref","is-referenced-by-count":83,"title":["Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting"],"prefix":"10.1002","volume":"32","author":[{"given":"P.","family":"Barragan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sainsous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Comet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Sim\u00e9oni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Charmasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bremondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,26]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703193161201"},{"key":"e_1_2_1_3_2","first-page":"II","article-title":"Emergent coronary artery stenting for failed PTCA","volume":"84","author":"Hermann HC","year":"1991","journal-title":"Circulation"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.1.148"},{"key":"e_1_2_1_5_2","first-page":"1311","article-title":"Endoproth\u00e9ses coronariennes auto\u2010expansives dans la pr\u00e9vention des rest\u00e9noses apr\u00e9s angioplastie transluminale","volume":"80","author":"Puel J","year":"1987","journal-title":"Arch Mal Coeur"},{"key":"e_1_2_1_6_2","first-page":"I","article-title":"Subacute stent thrombosis in Palmaz\u2010Schatz stents in native coronary arteries: Time course, acute management and outcome. U.S. multicenter experience","volume":"86","author":"Shaknovich A","year":"1992","journal-title":"Circulation"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90523-N"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01833976"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(07)80005-6"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(07)80006-8"},{"key":"e_1_2_1_11_2","first-page":"I","article-title":"Predictors of thrombotic occlusion following coronary Palmaz\u2010Schatz stent implantation","volume":"86","author":"Doucet S","year":"1992","journal-title":"Circulation"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198734020-00003"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(83)90452-8"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101033240103"},{"key":"e_1_2_1_15_2","first-page":"II","article-title":"Antiplatelat agents are effective in reducing the immediate complications of PTCA: Results from the ticlopidine multicenter trial","volume":"76","author":"White CW","year":"1987","journal-title":"Circulation"},{"key":"e_1_2_1_16_2","first-page":"368","article-title":"Results of a randomized trial of ticlopidine versus placebo for prevention of acute closure and restenosis after PTCA. The TACT Study","author":"Bertrand ME","year":"1990","journal-title":"Eur Heart J"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90989-C"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93385-M"}],"container-title":["Catheterization and Cardiovascular Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.1810320208","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.1810320208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T07:14:48Z","timestamp":1698131688000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.1810320208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,6]]}},"alternative-id":["10.1002\/ccd.1810320208"],"URL":"https:\/\/doi.org\/10.1002\/ccd.1810320208","archive":["Portico"],"relation":{},"ISSN":["0098-6569","1097-0304"],"issn-type":[{"value":"0098-6569","type":"print"},{"value":"1097-0304","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,6]]}}}